HEMA Flashcards
Part of the vascular intima that is involve in clotting process by producing and storing clotting components
a. CT Matrix
b. Endothelium
c. Subendothelial Collagen
d. Subendothelial CT
b. Endothelium
Procoagulant property of a damaged vascular intima which binds vWF that binds and activates platelets
a. An exposed smooth muscle cells & fibroblast
b. An exposed subendothelial collagen
c. Damaged or activated endothelial cells that secretes vWF
d. Smooth muscles found in arterioles & arteries
b. An exposed subendothelial collagen
Properties of platelet wherein platelet binds to a non-platelet surface:
a. Adhesion
b. Aggregation
c. Secretion
a. Adhesion
The narrowing of the lumen of the blood vessels during primary hemostasis will:
a. Decrease the blood flow on the uninjured area of blood vessels
b. Increase the blood flow on the injured area of blood vessels
c. Release of circulating inhibitors in the plasma
d. Release of clotting properties of the endothelium
e. None
The conversion of membrane phospholipids to arachidonic acid during platelet secretion is the function of
a. Cyclooxygenase
b. Phospholipid A2
c. Thromboxane A2
d. Thromboxane Synthetase
e. None (phospholipase A2)
The conversion of arachidonic acid to prostaglandin endoperoxidase during platelet secretion is the function of:
a. Cyclooxygenase
b. Phospholipid A2
c. Thromboxane A2
d. Thromboxane Synthetase
a. Cyclooxygenase
A form of hereditary vascular disorder that has a vascular defect wherein the blood vessels are thin-walled with a discontinuous endothelium, inadequate smooth muscle, and inadequate or missing elastin in the surrounding stroma:
a. Ehlers-Danlos Syndrome
b. Louis-Bar Syndrome
c. Kasabach-Merritt Syndrome
d. Rendu-Osler-Weber Syndrome
d. Rendu-Osler-Weber Syndrome
A form of hereditary vascular disorder that has a vascular defect in collagen production, structure, or crosslinking, with resulting inadequacy of the connective issues:
a. Ehlers-Danlos Syndrome
b. Louis-Bar Syndrome
c. Kasabach-Merritt Syndrome
d. Rendu-Osler-Weber Syndrome
a. Ehlers-Danlos Syndrome
A form of hereditary vascular disorder which involves association of a giant cavernous hemangioma (vascular tumor), thrombocytopenia, and a bleeding diathesis:
a. Ehlers-Danlos Syndrome
b. Louis-Bar Syndrome
c. Kasabach-Merritt Syndrome
d. Rendu-Osler-Weber Syndrome
c. Kasabach-Merritt Syndrome
The following are acquired defects of platelet adhesion, except:
a. Anli-platelet antibodies
b. Chronic Liver Disease
c. Scott Syndrome
d. All of These
c. Scott Syndrome
An autosomal recessive thrombocytopenias which involves mutations in the NBLEA2 Gene:
a. Congenital Amegakaryocytic Thrombocytopenia
b. Immune Thrombocytopenia
c. Gray Platelet Syndrome
d. Wiskott-Aldrich Syndrome
c. Gray Platelet Syndrome
An even in the physiologic hemostasis wherein there is a gradual digestion and removal of the fibrin clot as healing of the injury occurs:
a. Coagulation
b. Fibrinolysis
c. Platelet Secretion
d. Vasoconstriction
b. Fibrinolysis
It is exposed from a disrupted subendothelial cells which activates the coagulation system through contact with plasma Factor VIl
a. Collagen
b. Tissue Factor
c. ТРА
d. Thrombomodulin
b. Tissue Factor
It binds to GP Ib/Ia receptors on adjacent platelets and joins them together in the presence of an ionized calcium.
a. Fibrillin
b. Fibrinogen
c. Fibronectin
b. Fibrinogen
The following coagulation factors are consumed during the process of coagulation except:
a. Antihemophilic Factor A
b. Fibrin Stabilizing Factor
c. Proaccelerin
d. Proconvertin
d. Proconvertin
The following are calcium and vitamin k independent coagulation factors, except:
a. Fitzgerald Factor
b. Fletcher Factor
c. PTA
d. PTC
d. PTC
The primary in vivo initiation mechanism for extrinsic coagulation cascade depends on the formation of
a. IXa: VIlla
b. TF.Via
c. TF:VIla
d. Xa:Va
c. TF:VIla
It is considered the marker of thrombosis and fibrinolysis:
a. Fragment D-E-D
b. Fragment E
c. Fragment X
d. Fragment Y
E. None (D-Dimer)
An intrinsic plasminogen activator secreled by the urinary tract epithelial cells, monocles and macrophages that convert plasminogen into its activated for:
a. PAl-1
b. TAFI
c. ТРА
d. UPA
d. UPA
It is considered the primary inhibitor of free plasmin:
a. A2-antiplasminogen
b. PAI-1
c. TAFI
d. TFPI
d. TFPI
The internal elastic lamina which primarily supports the endothelial cells are composed of
a. Collagen & Elastin
b. Collagen & Fibroblasts
c. Elastin & Proteases
d. Elastin & Zymogens
a. Collagen & Elastin
Bernard- soulier syndrome involves an abnormal platelet function due to this missing platelet membrane receptor:
a. GPIb/Ila Receptor
b. GPIb/Ila Receptor
c. GPIII Receptor
d. GPIla/lIb Receptor
e. NONE (GPIb/IX/V)
Glanzmann Thrombasthenia involves an abnormal platelet function due to this missing platelet membrane receptor:
a. GPIb/Ila Receptor
b. GPIb/Ila Receptor
c. GPIII Receptor
d. GPIla/lIb Receptor
e. NONE (GPIIb/IIIa)
The following are components of the platelet alpha-granules, except:
a. ATP
b. PDGF
c. Protein S
d. B-Thromboglobulin
a. ATP
FVI was removed & never reassigned as part of the blood clotting factors because:
a. It was determined to an activated form of contact factor
b. It was determined to be an activated form of proconvertin
c. It was determined to be an activated form of proaccelerin
d. It was determined to be an activated form of stable factor
c. It was determined to be an activated form of proaccelerin
Coagulation factors that are affected by coumadin (PIVKAS):
a. Prothrombin, Proaccelerin, PTA, Stuart Factor
b. Prothrombin, Proaccelerin, PTC, Stuart Factor
c. Prothrombin, Proconvertin, PTA, Stuart Factor
d. Prothrombin, Proconvertin, PTC, Stuart Factor
d. Prothrombin, Proconvertin, PTC, Stuart Factor
Initiation phase of the coagulation cascade will produce ________ of the total thrombin generated:
a. 2-3%
b. 3-5%
c. >95%
d. >99%
b. 3-5%
It is a cofactor to FVIla:
a. Contact Factor
b. Fletcher Factor
c. Labile Factor
d. Stable Factor
e. NONE (Tissue Factor)
TF:FVIla complex will activate low levels of:
a. Christmas & Stuart Factor
b. Labile & Stable Factor
c. Proconverlin & Proaccelerin
d. PTA & PTC
a. Christmas & Stuart Factor
These are activated by thrombin in the initiation phase bind to platelet membranes and become receptors for FX and FIXa:
a. Flla & FVa
b. FVa & FVIla
c. FVa & FVIlla
d. FXa & FVa
c. FVa & FVIlla
A rare autosomal recessive disorder characterized by a specific absence of morphologically recognizable alpha-granules in platelets.
a. Chediak-Higashi Syndrome
b. TAR Syndrome
c. Hermansky Pudlak Syndrome
d. Wiskott-Aldrich Syndrome
E. NONE (GPS)
An autosomal recessive disorder with a defective lysosomal function in variety of cells types with a tyrosine positive oculocutaneous albinism and a profound platelet dense granule deficiency.
a. Chediak-Higashi Syndrome
b. TAR Syndrome
c. Hermansky Pudlak Syndrome
d. Wiskott-Aldrich Syndrome
c. Hermansky Pudlak Syndrome